New York Department of Health to Allow Medical Cannabis as an Opioid Replacement | CashCropToday
0 Shares 919 Views

New York Department of Health to Allow Medical Cannabis as an Opioid Replacement

July 13, 2018
919 Views

Earlier this month, the New York State Department of Health announced new emergency regulations to allow patients prescribed opioids to be given a license to obtain medicinal cannabis as an alternative.

Opioids are synthetic based medicines that product effects similar to morphine. They are primarily used for pain management and are prescribed often by practitioners. Unfortunately the use of them has caused a wide spread epidemic. 91 Americans die everyday from opioid overdoses, more than car accidents and guns.

Medicinal cannabis has recently been found to be an all natural alternative to using opioids for the management of pain. Cannabis can also reduce the chance for dependence and as opposed to opioids, patients cannot overdose when consuming the plant. Most patients have reported that it is just as affection as using opioids.

Patients that qualify for this program will be given temporary registry ID cards that will allow them to purchase their medical cannabis.

“Medical marijuana has been shown to be an effective treatment for pain that may also reduce the chance of opioid dependence,” said New York State Health Commissioner Dr. Howard Zucker. “Adding opioid replacement as a qualifying condition for medical marijuana offers providers another treatment option, which is a critical step in combatting the deadly opioid epidemic affecting people across the state.”

Opioid replacement joins the following 12 qualifying conditions under the state’s Medical Marijuana Program: cancer; HIV infection or AIDS; amyotrophic lateral sclerosis (ALS); Parkinson’s disease; multiple sclerosis; spinal cord injury with spasticity; epilepsy; inflammatory bowel disease; neuropathy; Huntington’s disease; post-traumatic stress disorder; and chronic pain.

You may be interested

Green Growth Brands Raises C$85 Million Via Private Placement
Market Watch
4 views
Market Watch
4 views

Green Growth Brands Raises C$85 Million Via Private Placement

Editor - September 25, 2018

This morning, Green Growth Brands Ltd. announced that their company has raised C$85 million dollars via a private placement. The capital raise involved a series of strategic…

Cash Crop Today Interview with CEO of Open Grow™ João Melo
Growers
7 views
Growers
7 views

Cash Crop Today Interview with CEO of Open Grow™ João Melo

Editor - September 25, 2018

Open Grow™ is a company located in Portugal that is dedicated to the research and creation of automation solutions for the agricultural growing environments. Their company aims to…

Lender420 Provides Funding Solutions to Fit Your Company’s Equipment Needs
Market Watch
26 views
Market Watch
26 views

Lender420 Provides Funding Solutions to Fit Your Company’s Equipment Needs

Editor - September 24, 2018

Purchasing equipment involved in the cultivation, processing, manufacturing, and distribution of the cannabinoid-derived products can be one of the most expensive costs of setting up a successful…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: